BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Lifezone Metals
LZM
$366M
| $42.4K | ﹤0.01% |
+6,102
| New | +$42.4K |
|
3477
West Bancorporation
WTBA
$344M
| $42.2K | ﹤0.01% |
1,949
-1,635
| -46% | -$35.4K |
|
3478
Cerence
CRNC
$450M
| $42.2K | ﹤0.01% |
+5,375
| New | +$42.2K |
|
3479
Bowman Consulting
BWMN
$703M
| $42.2K | ﹤0.01% |
+1,691
| New | +$42.2K |
|
3480
Spire Global
SPIR
$307M
| $42.1K | ﹤0.01% |
+2,989
| New | +$42.1K |
|
3481
Atlanticus Holdings
ATLC
$1.09B
| $42K | ﹤0.01% |
753
-440
| -37% | -$24.5K |
|
3482
Capital Bancorp
CBNK
$551M
| $41.7K | ﹤0.01% |
1,463
-6,346
| -81% | -$181K |
|
3483
Latham Group
SWIM
$916M
| $41.6K | ﹤0.01% |
+5,972
| New | +$41.6K |
|
3484
Matrix Service
MTRX
$353M
| $41.5K | ﹤0.01% |
3,470
-5,695
| -62% | -$68.2K |
|
|
RVNC
3485
DELISTED
Revance Therapeutics, Inc.
RVNC
| $41.5K | ﹤0.01% |
13,662
-10,728
| -44% | -$32.6K |
|
3486
LCNB Corp
LCNB
$223M
| $41.4K | ﹤0.01% |
2,733
+200
| +8% | +$3.03K |
|
3487
MasterCraft Boat Holdings
MCFT
$362M
| $41.3K | ﹤0.01% |
2,165
-1,386
| -39% | -$26.4K |
|
|
ACRE
3488
Ares Commercial Real Estate
ACRE
$266M
| $41.3K | ﹤0.01% |
7,009
-4,724
| -40% | -$27.8K |
|
3489
PetMed Express
PETS
$57.8M
| $41.2K | ﹤0.01% |
8,555
+850
| +11% | +$4.1K |
|
3490
Spok Holdings
SPOK
$360M
| $41.1K | ﹤0.01% |
2,561
-1,276
| -33% | -$20.5K |
|
3491
Aquestive Therapeutics
AQST
$611M
| $41.1K | ﹤0.01% |
11,540
-7,286
| -39% | -$25.9K |
|
|
CANF
3492
Can-Fite BioPharma
CANF
$10.4M
| $40.9K | ﹤0.01% |
+25,185
| New | +$40.9K |
|
3493
Taysha Gene Therapies
TSHA
$837M
| $40.9K | ﹤0.01% |
+23,644
| New | +$40.9K |
|
3494
LG Display
LPL
$4.46B
| $40.8K | ﹤0.01% |
13,282
-48,740
| -79% | -$150K |
|
3495
Bankwell Financial Group
BWFG
$359M
| $40.6K | ﹤0.01% |
1,304
-586
| -31% | -$18.3K |
|
|
IGMS
3496
DELISTED
IGM Biosciences
IGMS
| $40.5K | ﹤0.01% |
+6,634
| New | +$40.5K |
|
3497
Investors Title Co
ITIC
$481M
| $40.5K | ﹤0.01% |
171
-369
| -68% | -$87.4K |
|
3498
Fortis
FTS
$24.9B
| $40.3K | ﹤0.01% |
970
-6
| -0.6% | -$249 |
|
|
CLLS
3499
Cellectis
CLLS
$290M
| $40.3K | ﹤0.01% |
22,400
+4,000
| +22% | +$7.2K |
|
|
TE
3500
T1 Energy Inc.
TE
$290M
| $40.2K | ﹤0.01% |
15,580
-39,995
| -72% | -$103K |
|